300 related articles for article (PubMed ID: 11557679)
1. LR11, a mosaic LDL receptor family member, mediates the uptake of ApoE-rich lipoproteins in vitro.
Taira K; Bujo H; Hirayama S; Yamazaki H; Kanaki T; Takahashi K; Ishii I; Miida T; Schneider WJ; Saito Y
Arterioscler Thromb Vasc Biol; 2001 Sep; 21(9):1501-6. PubMed ID: 11557679
[TBL] [Abstract][Full Text] [Related]
2. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
[TBL] [Abstract][Full Text] [Related]
3. Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells.
Ji ZS; Brecht WJ; Miranda RD; Hussain MM; Innerarity TL; Mahley RW
J Biol Chem; 1993 May; 268(14):10160-7. PubMed ID: 7683668
[TBL] [Abstract][Full Text] [Related]
4. Very-low-density lipoprotein binding to the apolipoprotein E receptor 2 is enhanced by lipoprotein lipase, and does not require apolipoprotein E.
Tacken PJ; Beer FD; Vark LC; Havekes LM; Hofker MH; Willems Van Dijk K
Biochem J; 2000 Apr; 347(Pt 2):357-61. PubMed ID: 10749663
[TBL] [Abstract][Full Text] [Related]
5. The 39-kDa receptor-associated protein regulates ligand binding by the very low density lipoprotein receptor.
Battey FD; Gåfvels ME; FitzGerald DJ; Argraves WS; Chappell DA; Strauss JF; Strickland DK
J Biol Chem; 1994 Sep; 269(37):23268-73. PubMed ID: 8083232
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of the binding of triglyceride-rich lipoproteins to the very low density lipoprotein receptor by apolipoprotein E and lipoprotein lipase.
Takahashi S; Suzuki J; Kohno M; Oida K; Tamai T; Miyabo S; Yamamoto T; Nakai T
J Biol Chem; 1995 Jun; 270(26):15747-54. PubMed ID: 7797576
[TBL] [Abstract][Full Text] [Related]
7. Blockade of the alpha 2-macroglobulin receptor/low-density-lipoprotein-receptor-related protein on rat liver parenchymal cells by the 39-kDa receptor-associated protein leaves the interaction of beta-migrating very-low-density lipoprotein with the lipoprotein remnant receptor unaffected.
Ziere GJ; van der Kaaden ME; Vogelezang CJ; Boers W; Bihain BE; Kuiper J; Kruijt JK; van Berkel TJ
Eur J Biochem; 1996 Dec; 242(3):703-11. PubMed ID: 9022700
[TBL] [Abstract][Full Text] [Related]
8. In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway.
Jong MC; Dahlmans VE; van Gorp PJ; van Dijk KW; Breuer ML; Hofker MH; Havekes LM
J Clin Invest; 1996 Nov; 98(10):2259-67. PubMed ID: 8941642
[TBL] [Abstract][Full Text] [Related]
9. Defective VLDL metabolism and severe atherosclerosis in mice expressing human apolipoprotein E isoforms but lacking the LDL receptor.
Knouff C; Briand O; Lestavel S; Clavey V; Altenburg M; Maeda N
Biochim Biophys Acta; 2004 Aug; 1684(1-3):8-17. PubMed ID: 15450205
[TBL] [Abstract][Full Text] [Related]
10. Conformation of apolipoprotein E both in free and in lipid-bound form may determine the avidity of triglyceride-rich lipoproteins to the LDL receptor: structural and kinetic study.
Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
Biochim Biophys Acta; 2000 Feb; 1484(1):14-28. PubMed ID: 10685027
[TBL] [Abstract][Full Text] [Related]
11. LR11/SorLA links triglyceride-rich lipoproteins to risk of developing cardiovascular disease in FH patients.
Vongpromek R; Bujo H; Hoekstra M; Schneider WJ; van der Zee L; Schinkel AF; Korporaal SJ; Dik WA; Ebinuma H; Jiang M; Verhoeven AJ; Sijbrands EJ; Mulder MT
Atherosclerosis; 2015 Dec; 243(2):429-37. PubMed ID: 26520897
[TBL] [Abstract][Full Text] [Related]
12. VLDL receptor mediates the uptake of human chylomicron remnants in vitro.
Niemeier A; Gàfvels M; Heeren J; Meyer N; Angelin B; Beisiegel U
J Lipid Res; 1996 Aug; 37(8):1733-42. PubMed ID: 8864957
[TBL] [Abstract][Full Text] [Related]
13. Reversal of hyperlipidaemia in apolipoprotein C1 transgenic mice by adenovirus-mediated gene delivery of the low-density-lipoprotein receptor, but not by the very-low-density-lipoprotein receptor.
Jong MC; van Dijk KW; Dahlmans VE; Van der Boom H; Kobayashi K; Oka K; Siest G; Chan L; Hofker MH; Havekes LM
Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):281-7. PubMed ID: 10024503
[TBL] [Abstract][Full Text] [Related]
14. Expression of LR11, a mosaic LDL receptor family member, is markedly increased in atherosclerotic lesions.
Kanaki T; Bujo H; Hirayama S; Ishii I; Morisaki N; Schneider WJ; Saito Y
Arterioscler Thromb Vasc Biol; 1999 Nov; 19(11):2687-95. PubMed ID: 10559012
[TBL] [Abstract][Full Text] [Related]
15. Characterization of lipoprotein receptors on rat Fu5AH hepatoma cells.
Friedman G; Wernette-Hammond ME; Hui DY; Mahley RW; Innerarity TL
J Lipid Res; 1987 Dec; 28(12):1482-94. PubMed ID: 2828502
[TBL] [Abstract][Full Text] [Related]
16. Variable heparan sulfate proteoglycan binding of apolipoprotein E variants may modulate the expression of type III hyperlipoproteinemia.
Ji ZS; Fazio S; Mahley RW
J Biol Chem; 1994 May; 269(18):13421-8. PubMed ID: 8175773
[TBL] [Abstract][Full Text] [Related]
17. Uptake of canine beta-very low density lipoproteins by mouse peritoneal macrophages is mediated by a low density lipoprotein receptor.
Koo C; Wernette-Hammond ME; Innerarity TL
J Biol Chem; 1986 Aug; 261(24):11194-201. PubMed ID: 3733751
[TBL] [Abstract][Full Text] [Related]
18. Lipoprotein metabolism by macrophages from atherosclerosis-susceptible White Carneau and resistant Show Racer pigeons.
Adelman SJ; St Clair RW
J Lipid Res; 1988 May; 29(5):643-56. PubMed ID: 3411239
[TBL] [Abstract][Full Text] [Related]
19. Effects of apolipoprotein E, beta-very low density lipoproteins, and cholesterol on the extension of neurites by rabbit dorsal root ganglion neurons in vitro.
Handelmann GE; Boyles JK; Weisgraber KH; Mahley RW; Pitas RE
J Lipid Res; 1992 Nov; 33(11):1677-88. PubMed ID: 1464751
[TBL] [Abstract][Full Text] [Related]
20. Very low density lipoprotein receptor binds apolipoprotein E2/2 as well as apolipoprotein E3/3.
Takahashi S; Oida K; Ookubo M; Suzuki J; Kohno M; Murase T; Yamamoto T; Nakai T
FEBS Lett; 1996 May; 386(2-3):197-200. PubMed ID: 8647281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
